美泊利单抗用于治疗与冠状动脉痉挛相关的阿司匹林加重性呼吸疾病。 - Suppr

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

作者信息

Hagin David, Shacham Yacov, Kivity Shmuel, Benor Shira

机构信息

Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel.

Department of Cardiology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel.

出版信息

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1076-1077. doi: 10.1016/j.jaip.2018.07.045. Epub 2018 Aug 29.

DOI:10.1016/j.jaip.2018.07.045

PMID:30172017

Abstract

摘要

相似文献

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1076-1077. doi: 10.1016/j.jaip.2018.07.045. Epub 2018 Aug 29.

Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.

Ann Allergy Asthma Immunol. 2019 Sep;123(3):311-312. doi: 10.1016/j.anai.2019.06.012. Epub 2019 Jun 24.

Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with aspirin-exacerbated respiratory disease.

Ann Allergy Asthma Immunol. 2020 Jan;124(1):102-104. doi: 10.1016/j.anai.2019.09.023. Epub 2019 Oct 9.

A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease.

J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1045-1047. doi: 10.1016/j.jaip.2018.01.038. Epub 2018 Mar 6.

Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.

Clin Exp Allergy. 2023 Sep;53(9):974-977. doi: 10.1111/cea.14348. Epub 2023 May 29.

Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series.

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1384-1385. doi: 10.1016/j.jaip.2020.09.007. Epub 2020 Sep 19.

Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease.

Ann Allergy Asthma Immunol. 2021 Jun;126(6):738-739. doi: 10.1016/j.anai.2021.03.010. Epub 2021 Mar 19.

Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease.

J Investig Allergol Clin Immunol. 2015;25(2):133-5.

Aspirin-Exacerbated Respiratory Disease in a Pediatric Patient Treated with Mepolizumab.

Arch Bronconeumol (Engl Ed). 2019 Jan;55(1):55-57. doi: 10.1016/j.arbres.2018.04.012. Epub 2018 May 28.

Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin-Exacerbated Respiratory Disease.

J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1215-1219. doi: 10.1016/j.jaip.2016.04.028. Epub 2016 Jul 7.

引用本文的文献

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.

Allergy Asthma Clin Immunol. 2020 Apr 22;16:27. doi: 10.1186/s13223-020-00423-3. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

作者信息

Hagin David, Shacham Yacov, Kivity Shmuel, Benor Shira

机构信息

Allergy and Clinical Immunology Unit, Department of Medicine, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel.

Department of Cardiology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel.

出版信息

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1076-1077. doi: 10.1016/j.jaip.2018.07.045. Epub 2018 Aug 29.

DOI:10.1016/j.jaip.2018.07.045

PMID:30172017

Abstract

摘要

相似文献

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1076-1077. doi: 10.1016/j.jaip.2018.07.045. Epub 2018 Aug 29.

Mepolizumab utility in successful aspirin desensitization in aspirin-exacerbated respiratory disease in a refractory case.

Ann Allergy Asthma Immunol. 2019 Sep;123(3):311-312. doi: 10.1016/j.anai.2019.06.012. Epub 2019 Jun 24.

Poor control of asthma symptoms with interleukin-5 inhibitors in four patients with aspirin-exacerbated respiratory disease.

Ann Allergy Asthma Immunol. 2020 Jan;124(1):102-104. doi: 10.1016/j.anai.2019.09.023. Epub 2019 Oct 9.

A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease.

J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1045-1047. doi: 10.1016/j.jaip.2018.01.038. Epub 2018 Mar 6.

Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.

Clin Exp Allergy. 2023 Sep;53(9):974-977. doi: 10.1111/cea.14348. Epub 2023 May 29.

Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series.

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1384-1385. doi: 10.1016/j.jaip.2020.09.007. Epub 2020 Sep 19.

Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease.

Ann Allergy Asthma Immunol. 2021 Jun;126(6):738-739. doi: 10.1016/j.anai.2021.03.010. Epub 2021 Mar 19.

Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease.

J Investig Allergol Clin Immunol. 2015;25(2):133-5.

Aspirin-Exacerbated Respiratory Disease in a Pediatric Patient Treated with Mepolizumab.

Arch Bronconeumol (Engl Ed). 2019 Jan;55(1):55-57. doi: 10.1016/j.arbres.2018.04.012. Epub 2018 May 28.

Eosinophilia-Associated Coronary Artery Vasospasm in Patients with Aspirin-Exacerbated Respiratory Disease.

J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1215-1219. doi: 10.1016/j.jaip.2016.04.028. Epub 2016 Jul 7.

引用本文的文献

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.

Allergy Asthma Clin Immunol. 2020 Apr 22;16:27. doi: 10.1186/s13223-020-00423-3. eCollection 2020.

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Mepolizumab for the treatment of aspirin-exacerbated respiratory disease associated with coronary spasm.

作者信息

机构信息

出版信息

相似文献

引用本文的文献